Details

Autor(en) / Beteiligte

• McMeniman, W.J., FANZCA
• Chard, R.B., FCSANZ
• Norrie, J., FANZCA
• Posen, J., FRCPA

Titel

Cardiac Surgery and Heparin Induced Thrombocytopaenia (HIT): A Case Report and Short Review

Ist Teil von

• Heart, lung & circulation, 2012-05, Vol.21 (5), p.295-299

Ort / Verlag

Australia: Elsevier B.V

Erscheinungsjahr

2012

Quelle

Elsevier ScienceDirect Journals

Beschreibungen/Notizen

• This patient presented for emergency cardiac surgery following two episodes of thrombocytopaenia, one before and one associated with exposure to unfractionated heparin in a seven-week period of intensive care management. Although the diagnosis of heparin induced thrombocytopaenia (HIT) was uncertain on clinical grounds when assessed by current criteria [5,21] , the positive antibody status directed management in accordance with the internationally recognised guidelines published by the American College of Chest Physicians (ACCP) Evidence-based Clinical Practice Guidelines [4]. An alternative anticoagulant to unfractionated heparin was indicated for cardiopulmonary bypass. Bivalirudin was selected because of recent literature supporting its safe use [2,4,6,7,8,9,21].